Despite Effectiveness, Accelerated Approval For Acute Hepatic Porphyria Drug in Doubt
According to a story from wtvbam.com, the drug development company Alnylam Pharmaceuticals has recently stated that it is looking less likely that its gene silencing therapy givosiran will be getting…